Freestone Capital Holdings, LLC Anavex Life Sciences Corp. Transaction History
Freestone Capital Holdings, LLC
- $2.67 Billion
- Q1 2024
A detailed history of Freestone Capital Holdings, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 13,800 shares of AVXL stock, worth $62,238. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,800
Previous 13,800
-0.0%
Holding current value
$62,238
Previous $128,000
45.31%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AVXL
# of Institutions
159Shares Held
31.6MCall Options Held
910KPut Options Held
1.35M-
State Street Corp Boston, MA7.3MShares$32.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$30 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$19.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$7.72 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC851KShares$3.84 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $352M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...